(3aR,8aS)-2-(6-Cyclohexylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole

Catalog No. :
ACXSHO151
CAS No. :
2417767-40-7
Molecular Formula :
C21H22N2O
Molecular Weight :
318.42

IUPAC Name:(3aR,8aS)-2-(6-cyclohexylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole

(3aR,8aS)-2-(6-Cyclohexylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3aR,8aS)-2-(6-Cyclohexylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
IUPAC Name(3aR,8aS)-2-(6-cyclohexylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
MDL No.-
Molecular FormulaC21H22N2O
Molecular Weight318.42
SMILESC1=CC(C2CCCCC2)=NC(C2=N[C@@H]3C4=CC=CC=C4C[C@@H]3O2)=C1
InChI KeyPVIZBTZTUGCFAO-VQTJNVASSA-N
Synonym8H-Indeno[1,2-d]oxazole, 2-(6-cyclohexyl-2-pyridinyl)-3a,8a-dihydro-, (3aS,8aR)-;(3AR,8aS)-2-(6-cyclohexylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole;(3aR,8aS)-2-(6-Cyclohexylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole;(3aS,8aR)-2-(6-Cyclohexylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole;(3aS,8aR)-2-(6-Cyclohexyl-2-pyridinyl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole;(3aR,8aS)-2-(6-Cyclohexylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole - [C89316]
CAS No.2417767-40-7

Synthetic Route by SureRoute

1. ACXSHO151 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXSHO151 route product structure diagram
    ACXSHO1512417767-40-7
Inquiry

2. ACXSHO151 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXSHO151 route product structure diagram
    ACXSHO1512417767-40-7
Inquiry

Comments (0)